
1/6 🚀 Delighted to see our review out online in Nature Reviews Bioengineering: CRISPR–Cas therapies targeting bacteria. Read: doi.org/10.1038/s44222-025-0…
CRISPR–Cas therapies targeting bacteria bit.ly/3RZbnJ5

Working on the spread of antibiotic-resistance plasmids and the role of plasmid-encoded CRISPR-Cas currently postdoc @institutpasteur previously phd @ETH

1/6 🚀 Delighted to see our review out online in Nature Reviews Bioengineering: CRISPR–Cas therapies targeting bacteria. Read: doi.org/10.1038/s44222-025-0…
CRISPR–Cas therapies targeting bacteria bit.ly/3RZbnJ5

Massive effort lead by the amazing @FabBenz to discuss the present and future of CRISPR-based antimicrobials ⚡
CRISPR–Cas therapies targeting bacteria bit.ly/3RZbnJ5

CRISPR–Cas therapies targeting bacteria bit.ly/3RZbnJ5

ps this is my last post on X — you can find me on 💙 under fabbenz for plasmid eco-evo and CRISPRy subjects

6/6 🙏 Huge thanks to co-authors @BeatrizBeamud @RaphaelLaurenceau @amandinemairee @duportet @AntoineDecrulle & @dbikard. 👏 Shout-out to the academics pushing the boundaries and to innovators at @sniprbiome , @LocusBio , @EligoBio and others turning concepts into clinics

5/6 – Clinical opportunities 👩⚕️ First-in-human trials already show safety and efficacy—proof CRISPR therapeutics can work in humans!

4/6 – The big hurdles 🛡️ Bacterial defences — restriction–modification systems, anti-CRISPRs and mutational escape — and how to bypass them

3/6 – In-situ delivery 🚚 Engineered phages, conjugative plasmids & more — pros, cons, host range, cargo size and manufacturability. No one-size-fits-all!

2/6 – CRISPR-Cas strategies 🧰 Toolbox & design considerations to eliminate bacteria or their plasmids — and to engineer microbes in situ

Two Postdocs (Lausanne, Switzerland) Bacterial genomics in the context of evolutionary epidemiology, with potential projects including antibiotic resistance, HGT and plasmid dynamics. with @sonjaklehtinen at University of Lausanne More details: iddjobs.org/jobs/bacterial-g…

Plasmid Biologists ‼️ ⚠️4 days left ⚠️ to sign up to join the #ISPB Virtual Seminar Series and submit your abstract for a talk. See you there 💥
📢 Can’t wait until the 2026 meeting to dive deeper into plasmids? Join the ISPB Virtual Seminars Series, an exciting initiative aimed at strengthening our community in 2025! 🤓 📅 Registration and abstract submission open until 20th January: docs.google.com/forms/d/e/1F…

The honor of being a 'Pasteurian' does not pay rent, certainly not in Paris… Fingers crossed for today's negotiations with @institutpasteur

For the past two years, we have been working on a novel approach to identify origins of transfer by conjugation in plasmids from any bacterial species. We are thrilled to see this work now published in @NatureMicrobiol after thorough peer review! nature.com/articles/s41564-0…

Fantastic PhD Opportunity on plasmid-phage interactions in Manchester with @c_igler and Mike Brockhurst👇also: the time in Germany would be spent in my lab
This tweet is unavailable

Make sure you don't miss it! 🤓
Excited to share our last collab paper in @NatureComms on the structure & interference mechanism of the mysterious 𝗧𝘆𝗽𝗲 𝗜𝗩-𝗔 𝗖𝗥𝗜𝗦𝗣𝗥-𝗖𝗮𝘀 system!! 🧬🚀 🔗nature.com/articles/s41467-0… 🧵 by @patrick_pausch below!

Should I stay or should I go? 🎶 In a new opinion piece, @c_igler, Andrina Bernhard and I discuss how conjugative plasmids and temperate bacteriophages balance vertical and horizontal transmission: ecoevorxiv.org/repository/vi… Our framework illuminates many sides of MGE biology (1/7)